홈 › 비소세포폐암 › 캘리포니아 › Santa Monica
CA Santa Monica의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 45개가 Santa Monica 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
피험자 모집 중3상
- Tower Cancer Research Foundation, Beverly Hills · 6마일 거리
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12마일 거리
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
피험자 모집 중3상
- Beverly Hills Cancer Center ( Site 0116), Beverly Hills · 6마일 거리
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
피험자 모집 중3상
- Tower Cancer Research Foundation, Beverly Hills · 6마일 거리
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11마일 거리
A Study of ZW251 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
피험자 모집 중1/2상
- UCLA - Santa Monica /ID# 271690, Santa Monica
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
피험자 모집 중3상
- Clinical Research Advisors, LLC, Beverly Hills · 6마일 거리
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
피험자 모집 중1상
- Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
피험자 모집 중3상
- Beverly Hills Cancer Center, Beverly Hills · 6마일 거리
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
피험자 모집 중1상
- ALX Center 11, Santa Monica
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
피험자 모집 중1상
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
피험자 모집 중관찰 연구
- UCLA Medical Center, Santa Monica
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
피험자 모집 중3상
- Beverly Hills Cancer Center ( Site 0070), Beverly Hills · 6마일 거리
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- Precision NextGen Oncology, Beverly Hills · 6마일 거리
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Kivu Trial Site, Santa Monica
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
피험자 모집 중3상
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
피험자 모집 중3상
- Research Site, Beverly Hills · 6마일 거리
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6마일 거리
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Research Site, Beverly Hills · 6마일 거리
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
피험자 모집 중3상
- Clinical Study Site, Beverly Hills · 6마일 거리
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
피험자 모집 중3상
- Sarcoma Oncology Center, Santa Monica
- University of California Los Angeles, Santa Monica
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- UCLA, Santa Monica
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
피험자 모집 중1상
- UCLA Health - Santa Monica Cancer Care, Santa Monica
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
피험자 모집 중1/2상
- UCLA - David Geffen School of Medicine, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · 6마일 거리
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Santa Monica
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- University of California, Los Angeles (UCLA), Santa Monica
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
피험자 모집 중1상
- Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills · 6마일 거리
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
피험자 모집 중1상
- UCLA Healthcare Hematology-Oncology, Santa Monica
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
피험자 모집 중1/2상
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6마일 거리
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
피험자 모집 중1상
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Research Site, Santa Monica
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
피험자 모집 중1상
- Sarcoma Oncology Center, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · 6마일 거리
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Tower Cancer Research Foundation, Beverly Hills · 6마일 거리
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
피험자 모집 중1상
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- UCLA, Santa Monica
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2/3상
- Tower Cancer Research Foundation, Beverly Hills · 6마일 거리
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11마일 거리
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12마일 거리
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Tower Cancer Research Foundation, Beverly Hills · 6마일 거리
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11마일 거리
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
피험자 모집 중2상
- Precision NextGen Oncology and Research Center, Beverly Hills · 6마일 거리
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
피험자 모집 중
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4마일 거리
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site 128, Santa Monica
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
피험자 모집 중1/2상
- Precision NextGen Oncology, Beverly Hills · 6마일 거리
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
피험자 모집 중1상
- Beverly Hills Cancer Center, Beverly Hills · 6마일 거리
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
피험자 모집 중1상
- Precision NextGen Oncology, Beverly Hills · 6마일 거리
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
Santa Monica의 다른 연구
- 유방암연구 29개
- 대장직장암연구 23개
- 암 (전체)연구 22개
- 전이성 암연구 19개
- 전립선암연구 15개
- 난소암연구 15개
- 폐암연구 15개
- 두경부 편평세포암연구 13개
- 심부전연구 11개
- 자궁내막암연구 10개
- 위암연구 9개
- 췌장암연구 9개
ClinicalTrials.gov 출처, 2026. 10. 7. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.